The report for Global Anti-Hypertensive Drugs Market of Market Research Future
comprises extensive primary research along with the detailed analysis of qualitative as well
as quantitative aspects by various industry experts, key opinion leaders to gain the deeper
insight of the market and industry performance. Anti-hypertensive drugs are used to treat
hypertension (high blood pressure). Hypertension is a state of chronic elevated arterial
blood pressure at or greater than 140/90 mm Hg for adults.
The Global Anti-Hypertensive Drugs Market was valued at $32.2 billion in 2015, and is
expected to reach $ 38.9 billion by 2022. Thus the market is expected to perform sluggish
growth at a CAGR of 2.73% from 2016 to 2022.
There exact cause of essential hypertension is unknown but is blamed on unhealthy lifestyle
and ageing. The major market driving factor for secondary hypertension are greater
detection and early diagnosis. Rise in the prevalence diseases such as kidney problems,
thyroid problems, adrenal gland tumors, heart ailments, chronic alcohol use etc. in which
anti-hypertensive are used are some of the other factors driving the growth of the market.
The constraints however are overwhelming and include patent expiries such as Actelion's
Tracleer (2015), and United Therapeutic's Remodulin (2014). Other blockbuster’s such as
Novartis's Diovan and Exforge, Sanofi Aventis's Avapro (2012) etc are also off-patent.
Key Players for Global Anti-Hypertensive Drugs Market:
Novartis AG, Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer Ingelheim, Sanofi
S.A., Astra Zeneca plc, Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceuticals
Company Limited, Pfizer Inc.
Segments:
Global Anti-Hypertensive Drugs Market has been segmented on the basis of pharmacological
class, hypertension type, disease source and Region.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2347 .
Regional Analysis of Global Anti-Hypertensive Drugs Market:
Globally North America is the largest market for global anti-hypertensive drugs. Europe is
the second-largest market for global anti-hypertensive drugs. The near future market for
anti-hypertensive drugs will be dominated by the developed regions with developing regions
providing a supporting role only. However the developing regions market particularly Asia
Pacific will be the fastest growing and is likely to be the key to the future.
The report gives the clear picture of current market scenario which includes historical and
projected market size in terms of value and volume, technological advancement, macro
economical and governing factors in the market. The report provides details information and
strategies of the top key players in the industry. The report also gives a broad study of the
different markets segments and regions.
Table Of Contents
1 Introduction
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Global Anti-Hypertensive Drugs Market, By Pharmacological Class
6 Global Anti-Hypertensive Drugs Market, By Hypertension Type
7 Global Anti-Hypertensive Drugs Market, By Disease Source
8 Global Anti-Hypertensive Drugs Market, By Regions
9 Company Landscape
10 Company Profile
11 Others
12 Appendix
… Toc Continued